{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:18:37Z","timestamp":1753877917639,"version":"3.41.2"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UNIFOR-FRIMED"},{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anders Jahres Fund for Medical Research"},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pluripotent stem cells provide opportunities for treating injuries and previously incurable diseases. A major concern is the immunogenicity of stem cells and their progeny. Here, we have dissected the molecular mechanisms that allow natural killer (NK) cells to respond to human pluripotent stem cells, investigating a wide selection of activating and inhibitory NK-cell receptors and their ligands. Reporter cells expressing the activating receptor NKG2D responded strongly to embryonic stem (ES) cell lines and induced pluripotent stem (iPS) cell lines, whereas reporter cells expressing the activating receptors NKp30, NKp46, KIR2DS1, KIR2DS2, and KIR2DS4 did not respond. Human ES and iPS cells invariably expressed several ligands for NKG2D. Expression of HLA-C and HLA-E was lacking or low, insufficient to trigger reporter cells expressing the inhibitory receptors KIR2DL1, -2DL2, or -2DL3. Similar results were obtained for the pluripotent embryonic carcinoma cell lines NTERA-2 and 2102Ep, and also iPS-cell-derived neural progenitor cells. Importantly, neural progenitor cells and iPS-cell-derived motoneurons also expressed B7H6, the ligand for the activating receptor NKp30. In line with these observations, IL-2-stimulated NK cells showed robust cytotoxic responses to ES and iPS cells as well as to iPS-cell-derived motoneurons. No significant differences in cytotoxicity levels were observed between KIR\/HLA matched and mismatched combinations of NK cells and pluripotent targets. Together, these data indicate that pluripotent stem cells and their neural progeny are targets for NK-cell killing both by failing to sufficiently express ligands for inhibitory receptors and by expression of ligands for activating receptors.<\/jats:p>","DOI":"10.1093\/stmcls\/sxae083","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T18:17:43Z","timestamp":1734805063000},"source":"Crossref","is-referenced-by-count":0,"title":["NK-cell cytotoxicity toward pluripotent stem cells and their neural progeny: impacts of activating and inhibitory receptors and KIR\/HLA mismatch"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4291-9600","authenticated-orcid":false,"given":"Camilla","family":"Henden","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo , N-0317 Oslo ,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hege B","family":"Fjerdingstad","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo , N-0317 Oslo ,","place":["Norway"]},{"name":"Norwegian Center for Stem Cell Research, Department of Immunology and Transfusion Medicine, Oslo University Hospital , N-0317 Oslo ,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth G","family":"Bj\u00f8rnsen","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo , N-0317 Oslo ,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavanya","family":"Thiruchelvam-Kyle","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo , N-0317 Oslo ,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R","family":"Daws","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo , N-0317 Oslo ,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marit","family":"Inngjerdingen","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Clinical Medicine, University of Oslo , N-0317 Oslo ,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel C","family":"Glover","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo , N-0317 Oslo ,","place":["Norway"]},{"name":"Norwegian Center for Stem Cell Research, Department of Immunology and Transfusion Medicine, Oslo University Hospital , N-0317 Oslo ,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Dissen","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo , N-0317 Oslo ,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"key":"2025032307122118700_CIT0001","doi-asserted-by":"publisher","first-page":"7634","DOI":"10.1073\/pnas.78.12.7634","article-title":"Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells","volume":"78","author":"Martin","year":"1981","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2025032307122118700_CIT0002","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature05934","article-title":"Generation of germline-competent induced pluripotent stem cells","volume":"448","author":"Okita","year":"2007","journal-title":"Nature."},{"key":"2025032307122118700_CIT0003","doi-asserted-by":"publisher","first-page":"21.8.1","DOI":"10.1002\/cphg.33","article-title":"Highly expandable human iPS cell-derived Neural Progenitor Cells (NPC) and neurons for central nervous system disease modeling and high-throughput screening","volume":"92","author":"Cheng","year":"2017","journal-title":"Curr Protoc Hum Genet"},{"key":"2025032307122118700_CIT0004","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/cells8010026","article-title":"Treatment of Parkinson\u2019s disease through personalized medicine and induced pluripotent stem cells","volume":"8","author":"Stoddard-Bennett","year":"2019","journal-title":"Cells"},{"key":"2025032307122118700_CIT0005","doi-asserted-by":"publisher","first-page":"12704","DOI":"10.1073\/pnas.0910106107","article-title":"Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury","volume":"107","author":"Tsuji","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2025032307122118700_CIT0006","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.stemcr.2016.01.012","article-title":"Cardiomyocytes derived from MHC-homozygous induced pluripotent stem cells exhibit reduced allogeneic immunogenicity in MHC-matched non-human primates","volume":"6","author":"Kawamura","year":"2016","journal-title":"Stem Cell Rep."},{"key":"2025032307122118700_CIT0007","doi-asserted-by":"publisher","first-page":"2515841418774433","DOI":"10.1177\/2515841418774433","article-title":"Regenerative medicine in the retina: from stem cells to cell replacement therapy","volume":"10","author":"Oswald","year":"-2018","journal-title":"Ther Adv Ophthalmol."},{"key":"2025032307122118700_CIT0008","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.cell.2010.07.039","article-title":"Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells","volume":"142","author":"Kobayashi","year":"2010","journal-title":"Cell."},{"key":"2025032307122118700_CIT0009","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1152\/physrev.00039.2017","article-title":"Induced pluripotent stem cells and their use in human models of disease and development","volume":"99","author":"Karagiannis","year":"2019","journal-title":"Physiol Rev."},{"key":"2025032307122118700_CIT0010","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3389\/fimmu.2017.00645","article-title":"The immunogenicity and immune tolerance of pluripotent stem cell derivatives","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol."},{"key":"2025032307122118700_CIT0011","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/jcmm.12062","article-title":"The tumourigenicity of iPS cells and their differentiated derivates","volume":"17","author":"Liu","year":"2013","journal-title":"J Cell Mol Med."},{"key":"2025032307122118700_CIT0012","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature12586","article-title":"Reprogramming in vivo produces teratomas and iPS cells with totipotency features","volume":"502","author":"Abad","year":"2013","journal-title":"Nature."},{"key":"2025032307122118700_CIT0013","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1002\/stem.471","article-title":"Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection","volume":"28","author":"Gutierrez-Aranda","year":"2010","journal-title":"Stem Cells."},{"key":"2025032307122118700_CIT0014","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1002\/stem.1757","article-title":"Neural stem cells differentiated from iPS cells spontaneously regain pluripotency","volume":"32","author":"Choi","year":"2014","journal-title":"Stem Cells."},{"key":"2025032307122118700_CIT0015","doi-asserted-by":"publisher","first-page":"10441","DOI":"10.1073\/pnas.1902566116","article-title":"Generation of hypoimmunogenic human pluripotent stem cells","volume":"116","author":"Han","year":"2019","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2025032307122118700_CIT0016","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","article-title":"Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"key":"2025032307122118700_CIT0017","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.stem.2013.08.003","article-title":"Toward the development of a global induced pluripotent stem cell library","volume":"13","author":"Turner","year":"2013","journal-title":"Cell Stem Cell."},{"key":"2025032307122118700_CIT0018","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s12015-024-10783-7","article-title":"Current landscape of iPSC haplobanks","volume":"20","author":"Escriba","year":"2024","journal-title":"Stem Cell Rev Rep"},{"key":"2025032307122118700_CIT0019","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.stemcr.2017.07.020","article-title":"NK cell alloreactivity against KIR-ligand-mismatched HLA-haploidentical tissue derived from HLA haplotype-homozygous iPSCs","volume":"9","author":"Ichise","year":"2017","journal-title":"Stem Cell Rep."},{"key":"2025032307122118700_CIT0020","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol."},{"key":"2025032307122118700_CIT0021","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood."},{"key":"2025032307122118700_CIT0022","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev-immunol-032712-100001","article-title":"Control of human viral infections by natural killer cells","volume":"31","author":"Jost","year":"2013","journal-title":"Annu Rev Immunol."},{"key":"2025032307122118700_CIT0023","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: natural killer cell activation and inhibition","volume":"9","author":"Lanier","year":"2008","journal-title":"Nat Immunol."},{"key":"2025032307122118700_CIT0024","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.4049\/jimmunol.1202926","article-title":"KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis","volume":"190","author":"Wong-Baeza","year":"2013","journal-title":"J Immunol."},{"key":"2025032307122118700_CIT0025","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.4049\/jimmunol.1300081","article-title":"HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors","volume":"191","author":"Goodridge","year":"2013","journal-title":"J Immunol."},{"key":"2025032307122118700_CIT0026","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nri1570","article-title":"MHC class I molecules and KIRs in human history, health and survival","volume":"5","author":"Parham","year":"2005","journal-title":"Nat Rev Immunol."},{"key":"2025032307122118700_CIT0027","doi-asserted-by":"publisher","first-page":"eaal5296","DOI":"10.1126\/sciimmunol.aal5296","article-title":"KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C","volume":"2","author":"Naiyer","year":"2017","journal-title":"Sci Immunol."},{"key":"2025032307122118700_CIT0028","doi-asserted-by":"publisher","first-page":"eadh1781","DOI":"10.1126\/sciimmunol.adh1781","article-title":"Innate receptors with high specificity for HLA class I-peptide complexes","volume":"8","author":"Sim","year":"2023","journal-title":"Sci Immunol."},{"key":"2025032307122118700_CIT0029","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.4049\/jimmunol.1600930","article-title":"The activating human NK cell receptor KIR2DS2 recognizes a beta(2)-microglobulin-independent ligand on cancer cells","volume":"198","author":"Thiruchelvam-Kyle","year":"2017","journal-title":"J Immunol."},{"key":"2025032307122118700_CIT0030","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature."},{"key":"2025032307122118700_CIT0031","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41590-018-0082-6","article-title":"Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells","volume":"19","author":"Hammer","year":"2018","journal-title":"Nat Immunol."},{"key":"2025032307122118700_CIT0032","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of human cytomegalovirus infection on the NK cell receptor repertoire","volume":"104","author":"Guma","year":"2004","journal-title":"Blood."},{"key":"2025032307122118700_CIT0033","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science."},{"key":"2025032307122118700_CIT0034","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/2326-6066.CIR-15-0098","article-title":"NKG2D receptor and its ligands in host defense","volume":"3","author":"Lanier","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"2025032307122118700_CIT0035","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1084\/jem.20090681","article-title":"The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans","volume":"206","author":"Brandt","year":"2009","journal-title":"J Exp Med."},{"key":"2025032307122118700_CIT0036","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/eji.201847746","article-title":"B7H6 is a functional ligand for NKp30 in rat and cattle and determines NKp30 reactivity toward human cancer cell lines","volume":"49","author":"Bjornsen","year":"2019","journal-title":"Eur J Immunol."},{"key":"2025032307122118700_CIT0037","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1182\/blood-2013-01-481705","article-title":"Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions","volume":"122","author":"Matta","year":"2013","journal-title":"Blood."},{"key":"2025032307122118700_CIT0038","doi-asserted-by":"publisher","first-page":"eadj7970","DOI":"10.1126\/sciimmunol.adj7970","article-title":"The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance","volume":"9","author":"Kilian","year":"2024","journal-title":"Sci Immunol."},{"key":"2025032307122118700_CIT0039","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/icb.2013.98","article-title":"Natural cytotoxicity receptors and their ligands","volume":"92","author":"Kruse","year":"2014","journal-title":"Immunol Cell Biol."},{"key":"2025032307122118700_CIT0040","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-05912-0","article-title":"The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells","volume":"616","author":"Sen Santara","year":"2023","journal-title":"Nature."},{"key":"2025032307122118700_CIT0041","doi-asserted-by":"publisher","first-page":"e2622","DOI":"10.1371\/journal.pone.0002622","article-title":"The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients\u2019 immune response","volume":"3","author":"Dressel","year":"2008","journal-title":"PLoS One."},{"key":"2025032307122118700_CIT0042","doi-asserted-by":"publisher","first-page":"e10192","DOI":"10.1371\/journal.pone.0010192","article-title":"Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells","volume":"5","author":"Suarez-Alvarez","year":"2010","journal-title":"PLoS One."},{"key":"2025032307122118700_CIT0043","doi-asserted-by":"publisher","first-page":"9864","DOI":"10.1073\/pnas.142298299","article-title":"Characterization of the expression of MHC proteins in human embryonic stem cells","volume":"99","author":"Drukker","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2025032307122118700_CIT0044","doi-asserted-by":"publisher","first-page":"e0125544","DOI":"10.1371\/journal.pone.0125544","article-title":"Human induced pluripotent stem cells are targets for allogeneic and autologous natural killer (NK) cells and killing is partly mediated by the activating NK receptor DNAM-1","volume":"10","author":"Kruse","year":"2015","journal-title":"PLoS One."},{"key":"2025032307122118700_CIT0045","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1634\/stemcells.2006-0022","article-title":"Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients","volume":"24","author":"Bonde","year":"2006","journal-title":"Stem Cells."},{"key":"2025032307122118700_CIT0046","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1096\/fj.09-134957","article-title":"Pluripotent stem cells are highly susceptible targets for syngeneic, allogeneic, and xenogeneic natural killer cells","volume":"24","author":"Dressel","year":"2010","journal-title":"FASEB J."},{"key":"2025032307122118700_CIT0047","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1634\/stemcells.2008-0528","article-title":"Role of natural-killer group 2 member D ligands and intercellular adhesion molecule 1 in natural killer cell-mediated lysis of murine embryonic stem cells and embryonic stem cell-derived cardiomyocytes","volume":"27","author":"Frenzel","year":"2009","journal-title":"Stem Cells."},{"key":"2025032307122118700_CIT0048","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1097\/TP.0000000000000063","article-title":"Natural killer cell subsets differentially reject embryonic stem cells based on licensing","volume":"97","author":"Perez-Cunningham","year":"2014","journal-title":"Transplantation."},{"key":"2025032307122118700_CIT0049","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.3389\/fimmu.2019.02580","article-title":"Natural killer cells prevent the formation of teratomas derived from human induced pluripotent stem cells","volume":"10","author":"Benabdallah","year":"2019","journal-title":"Front Immunol."},{"key":"2025032307122118700_CIT0050","doi-asserted-by":"publisher","first-page":"e85932","DOI":"10.1371\/journal.pone.0085932","article-title":"Physiological normoxia and absence of EGF is required for the long-term propagation of anterior neural precursors from human pluripotent cells","volume":"9","author":"Bilican","year":"2014","journal-title":"PLoS One."},{"key":"2025032307122118700_CIT0051","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.4049\/jimmunol.149.11.3535","article-title":"Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn 1","volume":"149","author":"Shenoy-Scaria","year":"1992","journal-title":"J Immunol."},{"key":"2025032307122118700_CIT0052","doi-asserted-by":"publisher","first-page":"5178","DOI":"10.4049\/jimmunol.1201983","article-title":"Identification of an MHC class I ligand for the single member of a killer cell lectin-like receptor family, KLRH1","volume":"189","author":"Daws","year":"2012","journal-title":"J Immunol."},{"key":"2025032307122118700_CIT0053","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0092-8674(78)90296-9","article-title":"Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis","volume":"14","author":"Barnstable","year":"1978","journal-title":"Cell."},{"key":"2025032307122118700_CIT0054","doi-asserted-by":"publisher","first-page":"eado6566","DOI":"10.1126\/sciadv.ado6566","article-title":"The nuclear export protein XPO1 provides a peptide ligand for natural killer cells","volume":"10","author":"Blunt","year":"2024","journal-title":"Sci Adv."},{"key":"2025032307122118700_CIT0055","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu Rev Immunol."},{"key":"2025032307122118700_CIT0056","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3389\/fimmu.2017.00870","article-title":"Efficient killing of murine pluripotent stem cells by natural killer (NK) cells requires activation by cytokines and partly depends on the activating NK receptor NKG2D","volume":"8","author":"Groschel","year":"2017","journal-title":"Front Immunol."},{"key":"2025032307122118700_CIT0057","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/35014520","article-title":"Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand","volume":"405","author":"Boyington","year":"2000","journal-title":"Nature."},{"key":"2025032307122118700_CIT0058","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/38028","article-title":"Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors","volume":"389","author":"Fan","year":"1997","journal-title":"Nature."},{"key":"2025032307122118700_CIT0059","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.4049\/jimmunol.1500447","article-title":"NK cells preferentially target tumor cells with a cancer stem cell phenotype","volume":"195","author":"Ames","year":"2015","journal-title":"J Immunol."},{"key":"2025032307122118700_CIT0060","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/stem.1422","article-title":"Natural killer cell-activating receptor NKG2D mediates innate immune targeting of allogeneic neural progenitor cell grafts","volume":"31","author":"Phillips","year":"2013","journal-title":"Stem Cells."},{"key":"2025032307122118700_CIT0061","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41467-017-00926-5","article-title":"MHC matching improves engraftment of iPSC-derived neurons in non-human primates","volume":"8","author":"Morizane","year":"2017","journal-title":"Nat Commun."},{"key":"2025032307122118700_CIT0062","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.stem.2020.05.008","article-title":"Metabolic reprograming via deletion of CISH in human iPSC-derived NK cells promotes in vivo persistence and enhances anti-tumor activity","volume":"27","author":"Zhu","year":"2020","journal-title":"Cell Stem Cell"}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/stmcls\/advance-article-pdf\/doi\/10.1093\/stmcls\/sxae083\/61253513\/sxae083.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/43\/3\/sxae083\/61253513\/sxae083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/43\/3\/sxae083\/61253513\/sxae083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T12:58:05Z","timestamp":1742734685000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/doi\/10.1093\/stmcls\/sxae083\/7930276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,10]]}},"URL":"https:\/\/doi.org\/10.1093\/stmcls\/sxae083","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"type":"print","value":"1066-5099"},{"type":"electronic","value":"1549-4918"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,12,21]]},"article-number":"sxae083"}}